Citation Impact
Citing Papers
Review of the clinical practice literature on allogeneic red blood cell transfusion
1997
Inadequate erythropoietin response to anemia: definition and clinical relevance
1994
Use of Epoetin and Darbepoetin in Patients With Cancer: 2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update
2007
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain
2015 StandoutNobel
Hypersensitivity from Intravenous Iron Products
2014
Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial
2004
The effect of anemia treatment on selected health-related quality-of-life domains: A systematic review
2003
Control of cancer-related anemia with erythropoietic agents:a review of evidence for improved quality of life and clinical outcomes
2003
Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
2016 StandoutNobel
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 Standout
Acute event‐related anaemia
2001
Newborn Hearing Screening — A Silent Revolution
2006 Standout
Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe*
2003
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial
2003 Standout
Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia
1995 Standout
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
1999 Standout
On improving the cost‐effectiveness of autologous blood transfusion practices
1994
Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: small molecule-based therapeutics for anemia
2010
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Retinopathy of prematurity
2013 Standout
Prevalence and outcomes of anemia in surgery: a systematic review of the literature
2004
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Chronic kidney disease
2011 Standout
Hemoglobin Targets for the Anemia of Chronic Kidney Disease
2004
The Cost Effectiveness of Preoperative Autologous Blood Donations
1995 Standout
Increased plasma viscosity as a reason for inappropriate erythropoietin formation.
1993 StandoutNobel
Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.
1997
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Diabetes in Asia
2009 Standout
Interleukin-10-deficient mice develop chronic enterocolitis
1993 Standout
Effects of Early and Late Intervention with Epoetin α on Left Ventricular Mass among Patients with Chronic Kidney Disease (Stage 3 or 4)
2004
Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy
2004
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Erythropoietin Treatment of Anemia Associated with Multiple Myeloma
1990
Guideline for the laboratory diagnosis of functional iron deficiency
2013
Zidovudine use but not weight‐based ribavirin dosing impacts anaemia during HCV treatment in HIV‐infected persons
2006
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
1995 Standout
Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines
2010
Sex, haemoglobin and kidney disease: new perspectives
2005
Epidemiology of Anemia Associated with Chronic Renal Insufficiency among Adults in the United States
2002
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
2011 Standout
Anemia treatment in the pre-ESRD period and associated mortality in elderly patients
2002
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Prevalence and outcomes of anemia in cancer: a systematic review of the literature
2004
Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx
2001
Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration.
1990
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 Standout
Selection of Mutant CHO Cells with Constitutive Activation of the HIF System and Inactivation of the von Hippel-Lindau Tumor Suppressor
2001 StandoutNobel
Effect of Early Correction of Anemia on the Progression of CKD
2006
Regulation of the Erythropoietin Gene
1989
Epoetin alfa improves quality of life in patients with cancer
2004
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Treatment of Sickle Cell Anemia with Hydroxyurea and Erythropoietin
1990
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 Standout
Chronic Kidney Disease
2016 Standout
Pre-eclampsia
2015 Standout
Impact of Erythropoiesis-Stimulating Agents on Energy and Physical Function in Nondialysis CKD Patients With Anemia: A Systematic Review
2009
Anemia of Chronic Disease
2005 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
An Analysis of Blood Management in Patients Having a Total Hip or Knee Arthroplasty*
1999 Standout
The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin
1991
Biochemistry, Physiology, and Complications of Blood Doping: Facts and Speculation
2006
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
2000
5 Amidines and Guanidines in Medicinal Chemistry
1993
Progress in understanding the pathogenesis of the anemia of chronic disease [see comments]
1992
Erythropoietin, iron, and erythropoiesis
2000
Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models
2001
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Anti-retroviral therapy of human immunodeficiency virus infection: current strategies and challenges for the future [published erratum appears in Blood 1991 Dec 15;78(12):3330]
1991
Use of Epoetin in Patients With Cancer: Evidence-Based Clinical Practice Guidelines of the American Society of Clinical Oncology and the American Society of Hematology
2002
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus
2009
Molecular Targets for AIDS Therapy
1990 Science
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.
1994 StandoutNobel
IGF-1 is an Independent Risk Factor for Anemia in Diabetic Pre-dialysis Patients
2007
Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an Inhibitor
1992 StandoutScience
Collection of autologous blood before elective hip replacement. A comparison of the results with the collection of two and four units.
1994
Regulation of hypoxia-inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain
2001 StandoutNobel
Additions to Metal-Activated Organonitriles
2002 Standout
A randomized trial of perioperative hemodilution versus transfusion of preoperatively deposited autologous blood in elective surgery
1992
Structure of a Covalently Trapped Catalytic Complex of HIV-1 Reverse Transcriptase: Implications for Drug Resistance
1998 StandoutScience
Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients
1995
Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement
1993
The Effect of Blood Transfusion Protocol on Retinopathy of Prematurity: A Prospective, Randomized Study
1999
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease
2010
The Quality of Life of Hemodialysis Recipients Treated With Recombinant Human Erythropoietin
1990
Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease
2006
Effect of recombinant human erythropoietin combined with granulocyte/ macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome
2000
Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments]
1994
A Critical Appraisal of the Quality of Quality-of-Life Measurements
1994 Standout
Pretreatment with Corticosteroids to Alleviate Reactions to Intravenous Contrast Material
1987
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
2005
Erythropoietin, iron, and erythropoiesis.
2000
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
2001
Iron-Deficiency Anemia
2015 Standout
Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes
1994 StandoutNobel
Erythropoietin, iron, and erythropoiesis
2000
Regulation of the Erythropoietin Gene
1999
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells.
1993 StandoutNobel
Inhibitors of human immunodeficiency virus integrase.
1993 StandoutNobel
Multiple Myeloma
2011 Standout
Language of Early- and Later-identified Children With Hearing Loss
1998 Standout
Anemia and Patient Blood Management in Hip and Knee Surgery
2010
Works of Robert Abels being referenced
Effects of Recombinant Human Erythropoietin on Renal Function in Chronic Renal Failure Predialysis Patients
1994
Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination Chemotherapy
1993
Recombinant Human Erythropoietin for Patients with AIDS Treated with Zidovudine
1990
Increased Preoperative Collection of Autologous Blood with Recombinant Human Erythropoietin Therapy
1989
A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy
1994
The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double‐blind, controlled trial
1996
The use of r‐HuEpo in the treatment of anaemia related to myelodysplasia (MDS)
1995
Treatment of the Anemia of Progressive Renal Failure with Recombinant Human Erythropoietin
1989
Clinical pharmacokinetics of etintidine
1988
The Use of Recombinant Human Erythropoietin in the Correction of Anemia in Predialysis Patients and Its Effect on Renal Function: A Double-Blind, Placebo-Controlled Trial
1989
Efficacy of intravenous pretesting and antihistamine prophylaxis in radiocontrast media-sensitive patients
1978
The Effects of Recombinant Human Erythropoietin on Perioperative Transfusion Requirements in Patients Having a Major Orthopaedic Operation*
1996
Recombinant Human Erythropoietin (rHuEPO) for the Treatment of the Anemia of Cancer
1996
Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
1994
Recombinant Human Erythropoietin Stimulates Erythropoiesis and Reduces Erythrocyte Transfusions in Very Low Birth Weight Preterm Infants
1995
Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.
2006
Recombinant human erythropoietin (r-HuEPO) for the treatment of the anemia of cancer
1991